Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

被引:358
作者
Ishibashi, Tadashi [1 ]
Horisawa, Tomoko [1 ]
Tokuda, Kumiko [1 ]
Ishiyama, Takeo [1 ]
Ogasa, Masaaki [1 ]
Tagashira, Rie [1 ]
Matsumoto, Kenji [1 ]
Nishikawa, Hiroyuki [1 ]
Ueda, Yoko [1 ]
Toma, Satoko [1 ]
Oki, Hitomi [1 ]
Tanno, Norihiko [1 ]
Saji, Ikutaro [1 ]
Ito, Akira [1 ]
Ohno, Yukihiro [1 ]
Nakamura, Mitsutaka [1 ]
机构
[1] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Osaka 5640053, Japan
关键词
REVERSES MK-801-INDUCED IMPAIRMENT; GUINEA-PIG; ANTAGONIST SB-269970; DOUBLE-BLIND; WATER MAZE; SCHIZOPHRENIA; RAT; BINDING; MEMORY; SM-9018;
D O I
10.1124/jpet.110.167346
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lurasidone [(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl) piperazin-1-ylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride; SM-13496] is an azapirone derivative and a novel antipsychotic candidate. The objective of the current studies was to investigate the in vitro and in vivo pharmacological properties of lurasidone. Receptor binding affinities of lurasidone and several antipsychotic drugs were tested under comparable assay conditions using cloned human receptors or membrane fractions prepared from animal tissue. Lurasidone was found to have potent binding affinity for dopamine D-2, 5-hydroxytryptamine 2A (5-HT2A), 5-HT7, 5-HT1A, and noradrenaline alpha(2C) receptors. Affinity for noradrenaline alpha(1), alpha(2A), and 5-HT2C receptors was weak, whereas affinity for histamine H-1 and muscarinic acetylcholine receptors was negligible. In vitro functional assays demonstrated that lurasidone acts as an antagonist at D-2 and 5-HT7 receptors and as a partial
引用
收藏
页码:171 / 181
页数:11
相关论文
共 49 条
[31]   Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial [J].
Nakamura, Mitsutaka ;
Ogasa, Masaaki ;
Guarino, John ;
Phillips, Debra ;
Severs, Joseph ;
Cucchiaro, Josephine ;
Loebel, Antony .
JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (06) :829-836
[32]   EVALUATION OF BRADYKINESIA INDUCTION BY SM-9018, A NOVEL 5-HT2 AND D-2 RECEPTOR ANTAGONIST, USING THE MOUSE POLE TEST [J].
OHNO, Y ;
ISHIDA, K ;
IKEDA, K ;
ISHIBASHI, T ;
OKADA, K ;
NAKAMURA, M .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 49 (01) :19-23
[33]  
Reynolds Gavin P, 2006, J Psychopharmacol, V20, P15, DOI 10.1177/1359786806066040
[34]   1192U90 in animal tests that predict antipsychotic efficacy, anxiolysis, and extrapyramidal side effects [J].
Rigdon, GC ;
Norman, MH ;
Cooper, BR ;
Howard, JL ;
Boncek, VM ;
Faison, WL ;
Nanry, KP ;
Pollard, GT .
NEUROPSYCHOPHARMACOLOGY, 1996, 15 (03) :231-242
[35]   Mice lacking 5-HT7 receptors show specific impairments in contextual learning [J].
Roberts, AJ ;
Krucker, T ;
Levy, CL ;
Slanina, KA ;
Sutcliffe, JG ;
Hedlund, PB .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (07) :1913-1922
[36]   GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus [J].
Roberts, C ;
Thomas, DR ;
Bate, ST ;
Kew, JNC .
NEUROPHARMACOLOGY, 2004, 46 (07) :935-941
[37]   Anxiolytic-like effects of perospirone, a novel serotonin-2 and dopamine-2 antagonist (SDA)-type antipsychotic agent [J].
Sakamoto, H ;
Matsumoto, K ;
Ohno, Y ;
Nakamura, M .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (04) :873-878
[38]   Pharmacological characterization and CNS effects of a novel highly selective α2C-adrenoceptor antagonist JP-1302 [J].
Sallinen, J. ;
Hoglund, I. ;
Engstrom, M. ;
Lehtimaki, J. ;
Virtanen, R. ;
Sirvio, J. ;
Wurster, S. ;
Savola, J-M ;
Haapalinna, A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (04) :391-402
[39]   Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants [J].
Santarelli, L ;
Saxe, M ;
Gross, C ;
Surget, A ;
Battaglia, F ;
Dulawa, S ;
Weisstaub, N ;
Lee, J ;
Duman, R ;
Arancio, O ;
Belzung, C ;
Hen, R .
SCIENCE, 2003, 301 (5634) :805-809
[40]   The 5-HT7 receptor is involved in allocentric spatial memory information processing [J].
Sarkisyan, Gor ;
Hedlund, Peter B. .
BEHAVIOURAL BRAIN RESEARCH, 2009, 202 (01) :26-31